[2] Clinical Trials Doses Across multiple clinical trials, retatrutide was evaluated in varying doses to determine optimal therapeutic windows for both weight loss and glycemic control
The Therapeutic Goods Administration's (TGA) warning covers the following glucagon-like peptide-1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and obesity: Semaglutide, sold as Ozempic, Wegovy Tirzepatide, sold as Mounjaro Dulaglutide, sold as Trulicity Liraglutide, sold as Saxenda The TGA said the products had the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION)
Units on an insulin syringe measure volume, not drug amount
Noom Med follows in second for buyers who want behavior-change coaching paired with their medication, with a $149 introductory month
Most adults should aim for adequate daily fluid intake (approximately 8-10 cups for many people), though needs vary based on activity level, climate, and medical conditions
